Encysive Pharmaceuticals

Encysive Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes synthetic and small-molecule compounds to meet global medical needs. The company's research and development projects focus on endothelium-related diseases, inflammatory cascades, and the treatment and prevention of vascular diseases. Its products include Argatroban for the treatment of heparin-induced thrombocytopenia, and an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension, congestive heart failure, and primary hypertension.